Hox genes play important roles in the specification of spatial identity during development of vertebrate embryos. Retinoic acid regulates the transcription of Hox genes in vertebrates. We identified an epidermal enhancer in the 5' flanking region of an ortholog of Hox1 (Ci-Hox1) in the ascidian Ciona intestinalis. This enhancer element drives the transcription of a lacZ reporter gene in the epidermis in the posterior trunk and the anterior tail region of tailbud-stage embryos. Inhibition of retinoic acid synthesis resulted in inactivation of the expression of the reporter gene. The enhancer contains a putative retinoic acid response element. When this element was mutagenized, the expression of the reporter gene disappeared from the epidermis. This sequence was also required for the response to exogenously administered retinoic acid. A heterodimeric nuclear receptor, consisting of the retinoic acid receptor and retinoid X receptor, bound to this sequence. These results indicate that retinoic acid directly activates the epidermal enhancer of Ci-Hox1. This is the first demonstration that retinoic acid is necessary for endogenous gene expression in ascidian embryos.
Introduction
Animals belonging to the phylum Chordata are characterized by a notochord, a dorsally located neural tube and a pharynx with gill slits (Gee, 1996) . Among chordates, ascidians, salps and larvaceans comprise a unique sub-phylum, Urochordata. The body plan of their tadpole-type larvae is greatly simplified but still retains the essence of chordate-specific features (Satoh and Jeffery, 1995; Di Gregorio and Levine, 1998) .
Therefore, urochordates are a suitable model system with which to study the evolution of the molecular mechanisms that establish the chordate-specific architecture of the body. Since retinoic acid (RA) seems to play important developmental roles only in chordates, it is proposed that the acquisition of RA-dependent developmental programs was a key event during the evolution of chordates (Fujiwara and Kawamura, 2003; Fujiwara, 2006) . RA is necessary for morphogenesis in vertebrate embryos. This was clearly demonstrated by targeted mutagenesis of genes encoding retinoic acid receptors (RARs) and a retinoic acid-synthesizing enzyme, RALDH2 Mendelsohn et al., 1994; Niederreither et al., 1999) . Particularly, RA regulates the formation of chordate-specific organs and tissues, including the neural tube, pharynx (branchial arches), paired limbs, and neural crest cells (for reviews see Fujiwara and Kawamura, 2003; Campo-Paysaa et al., 2008) .
RAR forms a heterodimer with retinoid X receptor (RXR), and binds to a specific DNA -4-sequence called the RA response element (RARE) within the enhancer region of target genes (Umesono et al., 1991; Bastien and Rochette-Egly, 2004) . Hox genes are important targets of RA signaling (Krumlauf et al., 1993; Marshall et al., 1996; Altman and Brivanlou, 2001 ).
Enhancer regions of Hox genes contain RAREs and a normal expression depends on RA (Marshall et al., 1996) . Three major chordate groups (vertebrates, urochordates and cephalochordates) possess RALDH2, RARs, and an RA-degrading cytochrome P450 enzyme (CYP26) (Cañestro et al., 2006) . Although genes encoding these proteins have been found in lophotrochozoans (mollusks and annelids), the morphogenetic role of RA seems restricted to neurite outgrowth in these taxa (Campo-Paysaa et al., 2008) . Therefore, the connection of RAR to Hox enhancer elements would have been a crucial event in the evolution of the chordate body plan.
In cephalochordate embryos, exogenously administered RA interfered with pharyngeal morphogenesis , differentiation of epidermal neurons (Schubert et al., 2004a) , and patterning of the central nervous system (Schubert et al., 2006 ).
An RA antagonist had opposite effects, suggesting that endogenous RA signaling is required for normal embryonic development (Schubert et al., 2004a (Schubert et al., , 2004b (Schubert et al., , 2006 . Hox1 plays a key role in mediating the actions of RA in most of these cases (Schubert et al., 2004b (Schubert et al., , 2006 .
The amphioxus Hox1 gene (AmphiHox-1) contains a functional RA response element (RARE) within its enhancer located in the 3' flanking region (Manzanares et al., 2000; Wada et al., -5-2006 ). The AmphiHox-1 enhancer directs reporter gene expression in the hindbrain and neural crest cells in embryos of chicks and mice (Manzanares et al., 2000) . Recent extensive phylogenetic analyses revealed that cephalochordates diverged earlier during the evolution of chordates, and urochordates are the closest relatives of vertebrates (Delsuc et al., 2006 (Delsuc et al., , 2008 .
Therefore, the pivotal role of RA in cephalochordates indicates that hard wiring of the RAR-Hox regulatory machinery had already been established in the common chordate ancestor.
In contrast to the case in cephalochordates, RA does not have a severe effect on morphogenesis in the embryo of the larvacean Oikopleura dioica, which belongs to the urochordates (Cañestro and Postlethwait, 2007) . RA did not affect the expression pattern of Hox1 or any other gene examined (Cañestro and Postlethwait, 2007) . The compact genome of this species does not contain Raldh2, RAR, and Cyp26 (Cañestro et al., 2006) . Thus, Cañestro and Postlethwait (2007) proposed that the regulatory input from RAR to Hox was disconnected early on in the evolution of the urochordate lineage.
The urochordate ascidian Ciona intestinalis is an emerging model system for studying embryonic development (Satoh, 2003) . In this species, exogenously administered RA enhances the expression of a variety of genes, including Ci-Hox1 (Ishibashi et al., , 2005 . Therefore, the RA signaling machinery is highly active in the C. intestinalis embryo, unlike the O. dioica embryo. The C. intestinalis genome contains a -6-single Hox1 gene, named Ci-Hox1 (Dehal et al., 2002; Ikuta et al., 2004) . Ci-Hox1 is expressed around the neck region and visceral ganglion of the nerve cord and in a restricted area of the epidermis Ikuta et al., 2004; Ikuta and Saiga, 2007; Imai et al., 2009 ). The epidermal Ci-Hox1 expression domain encompasses the posterior trunk to the anterior tail . RA treatment activates Ci-Hox1 expression in the entire epidermis . A microarray analysis revealed that the RA-induced activation occurred in the absence of translation, suggesting that pre-existing RAR directly activates the enhancer of Ci-Hox1 (Ishibashi et al., 2005) . Knockdown of Raldh2 using a specific morpholino oligonucleotide diminished the expression of Ci-Hox1, indicating that endogenous RA is essential for the Ci-Hox1 expression (Imai et al., 2009) . Despite the circumstantial evidence, no RARE has ever been identified in the enhancer regions of Ci-Hox1 or other targets in C. intestinalis. It has been unclear whether the expression of these genes requires the endogenous RA signal in normal embryos.
In the present study, we identified an epidermal enhancer of Ci-Hox1 within the 5' flanking region. We demonstrated that the Ci-RAR/Ci-RXR heterodimer binds to an RARE found in the enhancer. Mutation of this RARE diminished Ci-Hox1 expression in the epidermis, suggesting that RAR-mediated RA signaling directly activates Ci-Hox1 expression in the epidermis of normal C. intestinalis embryos.
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Materials and methods

Animals
C. intestinalis juvenile adults were kindly provided by Kazuko Hirayama and Nori Satoh at Kyoto University, through the National Bio-Resource Project of MEXT, Japan.
They were cultured in Tosa Bay near the Usa Marine Biological Institute. Eggs and sperm were surgically obtained from the gonoducts. Eggs were inseminated with non-self sperm.
Fertilized eggs were dechorionated with 0.05% actinase E (Kaken Pharm., Tokyo, Japan) and 1% sodium thioglycolate. The embryos were raised in agarose-coated Petri dishes.
Transgenes
Genomic DNA corresponding to the 5' flanking region of Ci-Hox1 was amplified by polymerase chain reaction (PCR) using the primers 1.0F
(5'-TAGATTGATGATTCAATATGAGGAACGTAATTTCG-3') and 1.0R
(5'-ACCGGGTATTCTAGATACGAATTCATCTTACACCT-3'). The italicized sequence in 1.0R corresponds to the translation initiation site located within the second exon (Fig. 1A) .
The PCR product was inserted into pGEM-T (Promega, Madison, WI), and then excised with -8-XhoI and XbaI. The recognition site of XhoI was located within the 5' flanking sequence (Fig. 1A) , while that of XbaI was the underlined sequence in 1.0R. This DNA fragment was inserted into the vector pSP72-1.27 (Corbo et al., 1997) digested with XhoI and XbaI. The resulting plasmid was named Ci-Hox1(1.0)/lacZ. The second intron of Ci-Hox1 was amplified by PCR, using 5'-CACCGGCTAGCAGTAAGTTGTAAAGTTTAACA-3' and 5'-CCATACCCGGGACTAAAACAGACACAAAACATTGT-3'. The product of the PCR was inserted into pGEM-T. A 1.9-kb central region of the intron was excised with SalI and XmnI, the recognition sites of which were located within the intronic sequence (Fig. 1A) .
This fragment was then inserted into Ci-Hox(1.0)/lacZ digested with XhoI and NruI, whose recognition sites were located within the 5' flanking region (Fig. 1A) . The resultant plasmid was called Ci-Hox1(intron2)/lacZ. Ci-Hox1(intron2)/lacZ was digested with BstBI and SpeI (Fig. 1A) . Cohesive ends created by these enzymes were blunted, using T4 DNA polymerase, and the circular plasmid was recovered by self-ligation. The resultant plasmid was called Ci-Hox1( BsSp)/lacZ.
For site-directed mutagenesis, the NcoI-SpeI fragment in Ci-Hox1(intron2)/lacZ was mutagenized as follows (see Figs 1A and 5A). A DNA fragment was amplified by PCR using 5'-GTTTTGCTCCCATGGCCTCGATC-3' (NcoI site is underlined) and 5'-GGTGAAAAtcTagaCGTTTGT-3' (XbaI site is underlined). The lower case letters in the latter primer were not complementary to the native Ci-Hox1 sequence. The product of the -9-PCR was inserted into pGEM-T. This plasmid was named Mut-X. Another DNA fragment was amplified by PCR using 5'-ACAAACGgctAgCTTTTCACC-3' (NheI site is underlined) and 5'-CTTTACCTACTAGTATAAAGC-3' (SpeI site is underlined). The lower case letters in the former primer were not complementary to the native Ci-Hox1 sequence. The product of the PCR was once inserted into pGEM-T, and then cut with NheI and SpeI. This restriction fragment was inserted into Mut-X digested with XbaI and SpeI. In this case, SpeI cut its recognition site within the vector sequence. The cohesive ends produced by NheI and XbaI were ligated. As a result, the putative RARE sequence, 5'-ATGAACTTTTCACCC-3' (underlines show putative binding sites for RAR and RXR), was mutagenized into 5'-GCTAGATTTTCACC-3' (underline shows the NheI/XbaI junction). After confirmation of the sequence, the mutagenized enhancer was excised from Mut-RARE with NcoI and SpeI, and replaced with the corresponding wild-type enhancer fragment in Ci-Hox1(intron2)/lacZ.
For construction of Ci-Hox1(0.9)/lacZ, genomic DNA corresponding to the 5' flanking region of Ci-Hox1 was amplified by PCR using the primers 0.9F (5'-GGGGTCGACGAACGATCATCATGCCAACAT-3') and 0.9R (5'-GGGGATCCTGCGGGGTGATGTGGTTGGTAT-3'). The amplified DNA fragment was digested with SalI and BamHI (underlined sequences in 0.9F and 0.9R, respectively) and inserted into pSP72-1.27. For construction of Ci-Hox1(del1)/lacZ, two different parts of the Ci-Hox1 5' flanking region were separately amplified by PCR. The primers used were 0.9F -10-and 0.9-del1-R (5'-GGGTCTAGATCCAATTTTAATATAAGAAAC-3') for the 5' fragment, and 0.9-del1-F (5'-GGGTCTAGATGTGACCGGACACTGGAAACA-3') and 0.9R for the 3' fragment. The recognition sites of XbaI are underlined. The 5' fragment was digested with SalI and XbaI, while the 3' fragment was digested with XbaI and BamHI. These fragments were inserted one by one into pSP72-1.27. As a result, a conserved sequence (element 1; see Ci-Hox1(del2)/lacZ was constructed by a similar method, except that the primers 0.9-del-2R
(5'-GGTCTAGAGCTTTCGGCGCGTTTCTCATTT-3') and 0.9-del2-F (5'-GGTCTAGAGCTGTTTTTACAAGATGAATAA-3') were used instead of 0.9-del1-R and 0.9-del1-F, respectively. As a result, another conserved sequence (element 2; see Fig. 4B , C) was replaced by the recognition site of XbaI. Ci-Hox1(0.9)mut/lacZ was also made by a similar method, except that mutF (5'-GGGGCTAGCTTTTCACCCTAGAGTGAAGAC-3') and mutR (5'-GGGTCTAGACGTTTGTTTGCTTATTATCTT-3') were used instead of 0.9-del1-F and 0.9-del1-R, respectively. In this case, mutF contained the recognition sequence of NheI, while mutR contained the recognition sequence of XbaI. Both of the DNA fragments were inserted into pSP72-1.27, where cohesive ends produced by NheI and XbaI were ligated. In this construct, a DR2-type RARE (5'-TGAACTTTTCACCC-3') was replaced by the sequence (5'-ctagCTTTTCACCC-3') (see Fig. 4B -D).
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Electroporation, drug administration, and detection of the expression of reporter genes
A large-scale preparation of plasmid DNA was carried out using QIAGEN tip-100 (QIAGEN, Valencia, CA). The plasmid DNA was dissolved in 500 l of 0.77 M mannitol at a concentration of 60 g/ml. The plasmid DNA was introduced into dechorionated embryos by electroporation as described by Corbo et al. (1997) .
Electroporated embryos were treated with 1 M all-trans RA (Sigma-Aldrich, St.
Louis, MO) in the presence or absence of 200 g/ml of puromycin (Sigma-Aldrich) for 1 h from the neurula stage. As a control, embryos were treated with 0.1% dimethylsulfoxide (DMSO), since the 1 mM RA stock was dissolved in DMSO. To inhibit RA synthesis, embryos were treated with 3,7-dimethyl-2,6-octadienal (citral) or 4-dimethylaminobenzaldehyde (DEAB) from the 32-cell stage to the middle tail bud stage.
As a control, embryos were treated with 0.1% DMSO or 0.1% ethanol, since the DEAB and citral stocks were dissolved in DMSO and in ethanol, respectively.
For the detection of lacZ mRNA, embryos were fixed with a solution containing 4% paraformaldehyde, 100 mM MOPS (pH 7.5) and 500 mM NaCl. Whole-mount in situ hybridization was performed essentially according to Mita and Fujiwara (2007) , except that the immunological detection of hybridization signals was carried out using a buffer containing 100 mM Tris-HCl (pH 7.5) and 150 mM NaCl, instead of phosphate-buffered saline. For the -12-detection of -galactosidase activity, embryos were fixed with 0.75% formaldehyde at room temperature for 30 min. The specimens were stained in seawater containing 120 g/ml of X-gal, 3 mM potassium ferrocyanide, 3 mM potassium ferricyanide, 1 mM MgCl 2 , 0.1% Tween20, and 0.75% formaldhyde. For immunological detection of -galactosidase, embryos were fixed with 3.5% formaldehyde at 4ºC for 3 h. The specimens were washed with phosphate-buffered saline containing 0.1% Triton X-100 (T-PBS), and were incubated at room temperature for 3 h in T-PBS containing 10% goat serum (Vector Laboratories, Burlingame, CA). The specimens were reacted with a monoclonal anti--galactosidase antibody (Promega) overnight at 4ºC. After washing with T-PBS, the specimens were stained with an Alexa488-conjugated anti-mouse IgG raised in goat (Molecular probes-Invitrogen, Tokyo, Japan). Fluorescent images were obtained using a C1si confocal microscope (Nikon, Tokyo, Japan).
Electrophoretic mobility shift assay (EMSA)
The entire translated region of Ci-RAR and Ci-RXR was obtained by PCR using KOD DNA polymerase (Toyobo, Osaka, Japan) and cDNA clones (ID citb035d16 and citb010c11, respectively) as templates (Satou et al., 2002) . The primers used for the amplification of Ci-RAR were AF (5'-TGAACGTTATGGAGTTTCAAGAACA-3') and AR -13-(5'-ACGAGGCTAGCTTATTCGACCTCGT-3'), while those for Ci-RXR were XF (5'-CATTGCCAACTACGGGGAATGGTTT-3') and XR (5'-CAGTGGCTAGCTCACAGGTTGGCGA-3'). Italicized sequences in AR and XR correspond to stop codons. The recognition site of NheI is underlined. The products of the PCR were digested with NheI. These DNA fragments were inserted into pCMX-hRAR (Umesono et al., 1991) digested with MscI and NheI. The resultant plasmids were named pCMX-Ci-RAR and pCMX-Ci-RXR, respectively. Using these plasmids as templates, the Ci-RAR and Ci-RXR proteins were produced, according to the protocol for the TNT-coupled Reticulocyte Lysate Systems (Promega).
The double-stranded DNA probe, named Ci-Hox1-DR2, was prepared by annealing the complementary oligonucleotides, 5'-AACAAACGATGAACTTTTCACCCTAGAGTG-3' and 5'-TTCACTCTAGGGTGAAAAGTTCATCGTTTG-3', where sequences corresponding to a putative RARE are underlined. The probe, named Ci-Hox1-DR2mut, was prepared by annealing the oligonucleotides, 5'-AACAAACGtctagCTTTTCACCCTAGAGTG-3' and 5'-TTCACTCTAGGGTGAAAAGctagaCGTTTG-3'. Lower case letters indicate mutagenized sites. The 5' end of both strands was labeled with a Redivue [ -32 P] adenosine triphosphate (GE healthcare, Buckinghamshire, UK). In vitro translated proteins and labeled double-stranded DNA probes were incubated in a binding buffer for 20 min at room temperature. The binding buffer contained 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5 mM -14-DTT, 4% glycerol, 0.5 mM EDTA, 1 mM MgCl 2 , 0.05 mg/ml of poly (dI-dC) poly (dI-dC), 0.5 mM ZnCl 2 , and 0.2 M all-trans retinoic acid. A 50-fold excess of unlabeled competitor DNA was added to the reaction buffer. As a non-specific competitor, the AP2 oligonucleotide supplied in the Gel Shift Assay System (Promega) was used. The autoradiogram was obtained using a BAS-2500 IP Reader (Fujifilm, Tokyo, Japan).
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Results
An epidermal enhancer of Ci-Hox1 is located within the 5' flanking region
The C. intestinalis genome contains a single Hox1 gene (Ikuta et al., 2004) . The
Ci-Hox1 gene consists of four exons (Fig. 1A) . A putative translation initiation site is located within the second exon (Fig. 1A) . The nucleotide sequence of Ci-Hox1 was compared with that of the ortholog of Hox1 in a related ascidian species, Ciona savignyi, using the VISTA Genome Browser (http://genome.lbl.gov/vista/index.shtml). We found a few blocks of conserved sequences within the 3.5-kb second intron (data not shown). We constructed a reporter gene, named Ci-Hox1(intron2)/lacZ, in which lacZ was fused downstream of the first 22 bp of the second exon (Fig. 1B) . It contained a genomic DNA fragment spanning from nucleotide position -894 (NruI site) to the first 11 bp of the translated region of Ci-Hox1 (Fig. 1B) . It also contained a 1.9-kb fragment, excised from the second intron with SalI and XmnI (Fig. 1B) . This fragment contained all the blocks of conserved sequences. Since the intronic fragment did not contain the 5' and 3' splice sites, it was fused upstream of the 5' flanking region (Fig. 1B) . The transgene was introduced into one-cell embryos by electroporation, and the expression of lacZ was visualized by the histochemical staining of -galactosidase activity (Fig. 1C) . Ci-Hox1(intron2)/lacZ was expressed in the -16-epidermis and neural tube. Epidermal expression was restricted to the posterior half of the trunk and the anterior third of the tail in tailbud stage embryos (Fig. 1C) . A fluorescent staining using a -galactosidase-specific antibody revealed that the expression in the neural tube was restricted to the neck, visceral ganglion and anterior nerve cord regions (Fig. 1C' ).
This pattern of expression was similar to that of endogenous Ci-Hox1, although the expression domain of the reporter gene seemed slightly wider than that of the endogenous gene . The expression of Ci-Hox1(intron2)/lacZ was activated by 1 M all-trans RA in the entire epidermis (Fig. 1E) . DMSO, the solvent used to make the stock solution of RA, did not affect the pattern of expression of the reporter gene (Fig. 1D) . The DNA fragment between the SpeI site (nucleotide position -118) and BstBI site in the intronic sequence was deleted from Ci-Hox1(intron2)/lacZ (Fig. 1B) . The resultant plasmid, named Ci-Hox1( BsSp)/lacZ, lost 775 bp of the 5' flanking region and 41 bp of intronic sequence through this deletion (Fig. 1B) . The epidermal expression of Ci-Hox1( BsSp)/lacZ was much weaker than that of Ci-Hox1(intron2)/lacZ (Fig. 1F) . In contrast, the expression of Ci-Hox1( BsSp)/lacZ in the neural tube was not affected (Fig. 1F) .
Although RA enhanced the expression of Ci-Hox1( BsSp)/lacZ in the epidermis to some extent, the responsiveness to RA was severely affected (Fig. 1G) . The expression of
Ci-Hox1( BsSp)/lacZ in the neural tube seemed slightly upregulated by RA (Fig. 1G ).
However, this was not clear because the anterior neural tube did not close and its constituent -17-cells remained outside and were not regularly arranged in the RA-treated embryo ; Fig. 1G ). The results suggest that the 5' flanking region contains an enhancer element important for activation in the epidermis. We focused our attention mainly on this epidermal enhancer element.
The epidermal enhancer of Ci-Hox1 is directly activated by RA
The response of the epidermal enhancer to RA was examined by simultaneously treating electroporated embryos with 1 M RA and 200 g/ml of a translational inhibitor, puromycin. Drug treatment was performed for 1 hour at the neurula stage just before the endogenous Ci-Hox1 gene starts to be expressed. The expression of lacZ mRNA was detected by in situ hybridization. Ci-Hox1(intron2)/lacZ was expressed in the epidermis and neural tube in DMSO-treated control embryos ( Fig. 2A) . All-trans RA activated the expression of Ci-Hox1(intron2)/lacZ in all epidermal cells, irrespective of the presence of puromycin ( Fig. 2B and C) . In contrast, RA did not activate the expression of Ci-Hox1( BsSp)/lacZ in the epidermal cells (Fig. 2D-F) . These results suggest that no protein synthesis is necessary for the RA-dependent activation of the epidermal enhancer of Ci-Hox1. This means that the RAR/RXR heterodimer binds and directly activates the enhancer.
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Activation of the epidermal enhancer of Ci-Hox1 requires endogenous RA
To investigate whether endogenous RA is necessary for the activation of the epidermal enhancer of Ci-Hox1, we tested the effect of inhibitors of RA synthesis (citral and
DEAB) on the expression of Ci-Hox1(intron2)/lacZ. Embryos carrying
Ci-Hox1(intron2)/lacZ were treated with citral or DEAB (Fig. 3) . Citral affected retinal development in zebrafish at 50~250 M (Marsh-Armstrong et al., 1994). DEAB caused specific morphogenetic defects in zebrafish embryos at 50~100 M (Kopinke et al., 2006) .
Since these drugs have never been used for ascidians, we treated the C. intestinalis embryo at various concentrations. Citral and DEAB inhibited the expression of Ci-Hox1(intron2)/lacZ
in a dose-dependent manner (Fig. 3) . The expression was affected in both the epidermis and neural tube (Fig. 3) . These results suggest that the activation of the CiHox1 enhancer needs endogenous RA. Since the development of citral-treated and DEAB-treated embryos seemed to be delayed (Fig. 3) , we examined the expression of Ci-Hox1(intron2)/lacZ at later stages. However, the expression was not activated in the later stage embryos (data not shown).
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An RARE-like sequence is necessary for the activity of the epidermal enhancer of Ci-Hox1
The nucleotide sequence of the 5' flanking region of Ci-Hox1 was compared with that of the C. savignyi Hox1 gene (Cs-Hox1), using the VISTA Genome Browser (Fig. 4A) .
We found two blocks of conserved sequences, named elements 1 and 2 (Fig. 4A) . Element 2 contained a sequence similar to the consensus RARE (Fig. 4B) . Typical RARE sequences are direct repeats of two half sites to which RAR and RXR bind (Umesono et al., 1991) .
The half sites (5'-AGGTCA-3' or sequences similar to it) are usually separated by two or five nucleotides. They are called DR2 and DR5, respectively. The complementary strand of the RARE-like sequence in element 2 (5'-GGGTGAaaAGTTCA-3') resembled DR2 (Fig. 4B ).
This nucleotide sequence was completely conserved in the corresponding region of the C.
savignyi genome (Fig. 4C) . To assess the activity of elements 1 and 2, we constructed a reporter gene, where lacZ was placed downstream of a genomic DNA fragment spanning from nucleotide position -853 (SalI site) to the putative translation initiation site (Fig. 4D) .
The reporter gene, named Ci-Hox1(0.9)/lacZ, contained the elements 1 and 2 (Fig. 4D ). It did not contain the intronic sequence. The expression of Ci-Hox1(0.9)/lacZ was mainly observed in the epidermis (Fig. 4D , Table 1 ). The epidermal expression was restricted to the posterior half of the trunk and the anterior third of the tail region (data not shown). This pattern of epidermal expression was similar to that obtained with Ci-Hox1(intron2)/lacZ.
-20-However, no expression was observed in the neural tube (Table 1) . Considering the expression pattern of Ci-Hox1( BsSp)/lacZ, a neural tube enhancer is thought to be located within the second intron ( Figs 1F and 2D) . We generated an internal deletion of element 1 or element 2 of Ci-Hox1(0.9)/lacZ (Fig. 4D) . The pattern of expression of
Ci-Hox1(del1)/lacZ, which did not contain element 1, was indistinguishable from that of Ci-Hox(0.9)/lacZ ( Table 1) . Ci-Hox1(del2)/lacZ did not contain element 2 (Fig. 4D) . No expression of lacZ mRNA was observed in the epidermis of the embryo carrying
Ci-Hox1(del2)/lacZ ( Table.1 ). Ci-Hox1(0.9)mut/lacZ contained point mutations in the RARE-like sequence (Fig. 4D, E) . The expression of Ci-Hox1(0.9)mut/lacZ was not detected in the epidermis (Table 1) . These results indicate that the DR2-type RARE-like sequence in element 2 is necessary for the activation of the epidermal enhancer of Ci-Hox1 in normal embryos.
To confirm that the RARE-like sequence in element 2 was specifically required for the epidermal enhancer, we generated the same mutation in Ci-Hox1(intron2)/lacZ (Fig. 5A ).
The resultant reporter gene was named Ci-Hox1(intron2)mut/lacZ (Fig. 5A ). As described above, Ci-Hox1(intron2)/lacZ was expressed in the epidermis and neural tube ( Fig. 5C ; see also Fig. 1E ). In contrast, Ci-Hox1(intron2)mut/lacZ was expressed exclusively in the neural tube in normal embryos (Fig. 5D ). The expression in the -21-neural tube served as an internal control, indicating that the embryos carried a sufficient amount of transgenes. RA did not strongly induce the expression of Ci-Hox1(intron2)mut/lacZ in the epidermis (Fig. 5E) . Thus, the RARE-like sequence in element 2 is important for the activation in the epidermis of normal embryos and the responsiveness to RA. The results also revealed that the RARE-like sequence is not required for the activation of the neural tube enhancer.
The RAR/RXR heterodimer binds to the RARE-like sequence.
We used an EMSA to test whether the RAR/RXR heterodimer binds the putative DR2-type RARE of Ci-Hox1. In vitro synthesized Ci-RAR, Ci-RXR and TC14-3 proteins were used for EMSA. TC14-3 was used as a control protein. TC14-3 is a galactose-binding Ca 2+ -dependent lectin, whose cDNA clone was isolated from the budding ascidian Polyandrocarpa misakiensis (Matsumoto et al., 2001 ). An oligonucleotide probe was designed to contain the putative RARE found in the 5' flanking region of Ci-Hox1. The probe was called, Ci-Hox1-DR2. A DNA/protein complex was formed when Ci-Hox1-DR2 was added to the reaction mixture containing Ci-RAR and Ci-RXR (Fig. 6, lane 3) . No shifted band was observed when Ci-Hox1-DR2 was mixed with either Ci-RAR or Ci-RXR only (Fig. 6, lanes 1 and 2) . TC14-3 did not form a complex with Ci-Hox1-DR2 (Fig. 6, -22-lane 4). The complex's formation was inhibited with a 50-fold molar excess of unlabeled CiHox1-DR2, but not with an oligonucleotide containing an AP2-binding sequence (Fig. 6,   lanes 6 and 7) . Another probe, named Ci-Hox1-DR2mut, was prepared, which contained point mutations within the putative RAR-binding sequence of Ci-Hox1-DR2.
Ci-Hox1-DR2mut did not form a complex with a mixture of Ci-RAR and Ci-RXR proteins (Fig. 6, lane 5) . The results indicate that the DR2-like sequence in the 5' flanking region of Ci-Hox1 is a genuine RARE that binds the Ci-RAR/Ci-RXR heterodimer.
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Discussion
Epidermal expression of Ci-Hox1 is activated by RA
In the present study, we identified an epidermal enhancer, lying within the 5' flanking region of the Ci-Hox1 gene. We found an RARE within the enhancer region. The Ci-RAR and Ci-RXR proteins bind this RARE. Since neither of these proteins formed a protein/DNA complex, Ci-RAR and Ci-RXR probably bind this sequence as a heterodimer.
Deletion or point mutation of the RARE sequence impaired the enhancer activity, suggesting that the binding of Ci-RAR and Ci-RXR to this sequence is necessary. This, in turn, suggests that the RA signal is required to activate the epidermal enhancer of Ci-Hox1 in normal embryos. This was supported by the results that the inhibition of RA synthesis by citral and DEAB diminished the activity of the enhancer. These findings are consistent with previous observations that RA activated the expression of endogenous Ci-Hox1 gene even in the presence of puromycin (Ishibashi et al., 2005) . The present study provides the first direct evidence that ascidian RAR and RXR proteins activate the enhancer of a target gene in response to the endogenous RA signal. Since the larvacean, O. dioica, does not contain an RAR-encoding gene in its genome, Cañestro and Postlethwait (2007) suggested that an RAR-independent pathway (e.g. protein kinase C-dependent signal transduction pathway) is -24-involved in the response of the Ci-Hox1 gene to RA. However, the input from Ci-RAR to
Ci-Hox has not been disconnected during the evolution of the ascidian lineage of the chordates. The RA-independent mechanism of establishing the tadpole-type larval body plan was possibly acquired as a derivative feature in the larvacean ancestor.
Epidermis-specific function of the RARE
The Ci-Hox1( BsSp)/lacZ reporter gene was expressed in the neural tube, although this gene did not contain the RARE in the 5' flanking region. This result suggests that the RARE, found in the present study, is not necessary for the activation of the neural tube enhancer that is probably located within the second intron of the Ci-Hox1 gene. However, Imai et al. (2009) showed that an Raldh2-specific morpholino oligonucleotide suppressed the expression of Ci-Hox1 in the neural tube. Correspondingly, the present study showed that the expression of Ci-Hox1(intron2)/lacZ was also diminished in the neural tube by citral and DEAB. The expression of Ci-Hox1( BsSp)/lacZ seemed slightly enhanced in the neural tube, although it was difficult to estimate the level of enhancement because of the impaired arrangement of the neural tube cells in RA-treated embryos. These observations could be explained by the existence of another RARE within the neural tube enhancer. The 3'
flanking region of the murine Hoxb1 gene contains two RARE sequences (Marshall et al., -25-1994; Huang et al., 1998) . One of them is required for the expression in the neural epithelium, and the other is responsible for the expression in the foregut (Marshall et al., 1994; Huang et al., 1998) . Ogura and Evans (1995) revealed that two RARE sequences in the Hoxb1 enhancer were accompanied in close proximity by distinct transcription factor-binding sites. Tissue-specific transcription factors are thought to occupy either site and modulate the activity of the RAR/RXR heterodimer, bringing about the tissue-specific function of the RARE sequences (Ogura and Evans, 1995) . The same binding site for the Drosophila Dorsal protein mediates transcriptional activation and repression in a context-dependent manner (Pan and Courey, 1992) . It is therefore reasonable to think that another RARE is located within the neural tube enhancer of Ci-Hox1, and mediates the neural tube-specific function of the Ci-RAR/Ci-RXR heterodimer. Further detailed analyses are necessary for characterization of the neural tube enhancer of Ci-Hox1.
Another pathway of RA-dependent transactivation of Ci-Hox1 in the epidermis
The Ci-Hox1( BsSp)/lacZ reporter gene did not lose all sensitivity to exogenously administered RA, even though it lacked the RARE. However, the response of Ci-Hox1( BsSp)/lacZ to RA was suppressed by puromycin. These observations suggest that the regulatory region of Ci-Hox1 contains another sequence element responsible for an -26-indirect response to RA. A plausible hypothesis is that the Ci-RAR/Ci-RXR heterodimer activates the transcription of a gene X, whose protein product activates the expression of Ci-Hox1. In this case, puromycin can diminish the expression of Ci-Hox1 by inhibiting the translation of the X mRNA. In vertebrates, cdx1 is a direct target of RAR (Houle et al., 2000) . The enhancer region of cdx1 contains an RARE that is required for normal expression (Houle et al., 2000 (Houle et al., , 2003 . The spatial expression of various Hox genes is directly or indirectly regulated by Cdx (Houle et al., 2003; Gaunt et al., 2004) . Imai et al. (2009) revealed that FGF8/17/18 activates the expression of Ci-Hox1 in the neck region of the neural tube. However, it is unclear whether RA is involved in this genetic cascade (Imai et al., 2009 ).
Evolution of the epidermal enhancer of Hox1 in the chordates.
Epidermal expression of Hox1 is also observed in the amphioxus Branchiostoma floridae (Holland and Garcia-Fernàndez, 1996) and the hemichordate Saccoglossus kowalevskii (Lowe et al., 2003) . Epidermal expression of Hox1 is a common feature of non-vertebrate deuterostomes. RA is involved in the region-specific expression of the amphioxus Hox1 (Schubert et al., 2004a) . RA also affected the pattern of expression of genes in epidermal sensory neurons (Schubert et al., 2004a) . Since epidermal sensory -27-neurons in the C. intestinalis larva show a well-organized spatial pattern (Takamura, 1998; Pasini et al., 2006) , it is of interest whether this pattern is regulated by Ci-RAR and Ci-Hox1.
The epidermal expression of Hox1 is regulated by RA in B. floridae (Schubert et al., 2004a ). The present finding that the epidermal expression of Hox1 is also regulated by RA during Ciona embryogenesis, strongly supports the homology of Hox1's epidermal expression between ascidian and amphioxus. Because Hox1 is also expressed in the epidermis of S.
kowalevskii, the expression of Hox1 in the epidermis likely predates the evolution of the neural tube (Lowe et al., 2003) . We provide evidence that in Ciona, the neural tube expression of Hox1 is regulated by a cis-regulatory element distinct from that for the epidermis, although both are dependent on RA. Thus, the expression of Hox1 in the chordate neural tube was probably made possible by novel cis-regulatory elements. In vertebrates, Hox gene expression is also observed in somitic and lateral plate mesoderm.
The new Hox code in the mesoderm may have also been acquired through new cis-regulatory elements. The elaborated body plan of vertebrates may have been established by this sequential co-opting of the Hox code.
In this respect, it is of interest how the regulatory mechanism for the epidermal expression of Hox is retained in vertebrates. Epidermal expression of vertebrate Hox1 is observed in the pharyngeal region. The epidermal cells play essential roles in the patterning of the vertebrate pharynx, where Hox genes might be involved. Alternatively, the epidermal -28-expression might be co-opted to the Hox code in the vertebrate neural crest, whose development is regulated by interaction between the neural tube and epidermis. AP-2 is the only transcription factor proved to be specifically involved in the neural crest expression of the vertebrate Hox genes. AP-2 is expressed in the entire epidermis in both ascidian and amphioxus. The present study suggested that an epidermis-specific co-factor activates the epidermal enhancer of Ci-Hox1 synergistically with the RAR/RXR heterodimer. AP-2 is a candidate for this co-factor, although it remains to be elucidated whether AP-2 is involved in the expression of Hox1 in the epidermis. Identification of the ascidian epidermal factor cooperating with the RAR/RXR heterodimer will clarify the evolutionary history of the epidermal Hox code, and its contribution to the evolution of the vertebrate body plan. Comparison of the RARE-like sequence (DR2-type RARE) and its mutagenized form (DR2-type RARE mut).
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